Ellen completed her Bachelor of Science (Hons I) at the University of Sydney in 2016. She is currently completing a PhD, with a research focus on utilising gene therapy for the treatment of viral infections. Through characterising novel RNA therapeutics – specifically siRNAs – and optimising their delivery on lipid nanoparticles, her research aims to contribute to developing i) a robust, broad-spectrum SARS(-CoV-1, 2 & beyond) antiviral and ii) an accessible, effective functional HIV cure.
PhD Student (IVPP); Research Assistant (BDP)
Ms Ellen Bowden-Reid
BSc (Hons Class I) - The University of Sydney 2016
Publications
Journal articles
Bowden-Reid E; Ledger S; Zhang Y; Di Giallonardo F; Aggarwal A; Stella AO; Akerman A; Milogiannakis V; Walker G; Rawlinson W; Turville S; Kelleher AD; Ahlenstiel C, 2023, 'Novel siRNA therapeutics demonstrate multi-variant efficacy against SARS-CoV-2', Antiviral Research, 217, http://dx.doi.org/10.1016/j.antiviral.2023.105677
2023